| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 134 |
| 1 | METHOTREXATE SODIUM | 128 |
| 2 | ADALIMUMAB | 127 |
| 3 | FLUOROURACIL | 121 |
| 4 | FLUOROURACIL CREAM, 0.5% | 121 |
| 5 | FUROSEMIDE | 119 |
| 6 | METHOTREXATE | 119 |
| 7 | DEXAMETHASONE | 116 |
| 8 | DEXAMETHASONE 1.5 MG | 116 |
| 9 | BEVACIZUMAB | 114 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SORBITOL | 10 | 0.0166 |
| 1 | PORFIMER SODIUM | 4 | 0.0117 |
| 2 | CARBON DIOXIDE | 1 | 0.0087 |
| 3 | SODIUM POLYSTYRENE SULFONATE | 13 | 0.0081 |
| 4 | PALIFERMIN | 3 | 0.0077 |
| 5 | OXACILLIN SODIUM | 8 | 0.0070 |
| 6 | ALUMINUM HYDROXIDE GEL | 1 | 0.0068 |
| 7 | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | 1 | 0.0067 |
| 8 | BODY CLEANSER | 4 | 0.0056 |
| 9 | BEVACIZUMAB-ADCD | 1 | 0.0049 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 392 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 260 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 247 |
| 3 | Platinum-based Drug [EPC] | 205 |
| 4 | Atypical Antipsychotic [EPC] | 186 |
| 5 | Benzodiazepine [EPC] | 173 |
| 6 | Microtubule Inhibitor [EPC] | 151 |
| 7 | Proton Pump Inhibitor [EPC] | 147 |
| 8 | Alkylating Drug [EPC] | 135 |
| 9 | Loop Diuretic [EPC] | 126 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 3 | 0.0077 |
| 1 | Vasoconstrictor [EPC] | 1 | 0.0033 |
| 2 | Adrenal Steroid Synthesis Inhibitor [EPC] | 3 | 0.0030 |
| 3 | Humanized Monoclonal Antibody Fragment [EPC] | 4 | 0.0028 |
| 4 | Asparagine-specific Enzyme [EPC] | 33 | 0.0024 |
| 5 | Sclerosing Agent [EPC] | 1 | 0.0022 |
| 6 | Tricyclic Antidepressant [EPC] | 1 | 0.0021 |
| 7 | Hematopoietic Stem Cell Mobilizer [EPC] | 3 | 0.0020 |
| 8 | Medium-chain Triglyceride [EPC] | 1 | 0.0018 |
| 9 | alpha-Glucosidase Inhibitor [EPC] | 7 | 0.0014 |